Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors.
Two polypeptides from secretory products of human hepatoma cells were isolated and characterized on the basis of their stimulation of maintenance and growth of human endothelial cells in serum-free cell culture. Both factors were purified to homogeneity by a combination of reverse-phase, ion exchange, and molecular filtration high performance liquid chromatography. One factor (endothelial cell growth factor (ECGF-2a) had Mr approximately 6,500 and pI near 6. The second (ECGF-2b) had Mr = 27,000 and a pI below 4.0. Both ECGF-2a and ECGF-2b exhibited single NH2-terminal sequences. The first 25 NH2-terminal residues of ECGF-2a and the first 49 residues of ECGF-2b were determined by gas-phase microsequencing. All clearly determined residues of ECGF-2a were identical with human pancreatic secretory trypsin inhibitor. All assignable residues of ECGF-2b were identical with urinary glycoprotein proteinase inhibitor (HI-30/EDC1). Both proteins are absent or at low levels in normal plasma and urine, but appear during acute inflammatory disease and cancer. Amino acid composition of ECGF-2a and ECGF-2b was also similar to human pancreatic secretory inhibitor and HI-30/EDC1, respectively. Both ECGF-2a and ECGF-2b inhibited bovine pancreatic trypsin (2 micrograms/ml) by 50% at 750 ng/ml. ECGF-2a and ECGF-2b stimulated endothelial cell number at a half-maximal dose of 50 ng/ml (8 nM) and 80 to 130 ng/ml (5 to 9 nM) protein, respectively. When assayed under identical conditions, no effect of either factor on human smooth muscle cells, human hepatoma cells, or human, rat, and mouse fibroblasts could be detected.
D000595:Amino Acid Sequence; D006528:Carcinoma, Hepatocellular / Q000032:analysis*; D002478:Cells, Cultured; D002850:Chromatography, Gel; D003201:Computers; D016228:Endothelial Growth Factors; D004727:Endothelium / Q000166:cytology / Q000187:drug effects; D006133:Growth Substances / Q000032:analysis*; D006801:Humans; D008113:Liver Neoplasms / Q000032:analysis*; D008970:Molecular Weight; D009130:Muscle, Smooth / Q000166:cytology / Q000187:drug effects; D011480:Protease Inhibitors / Q000032:analysis*; D014361:Trypsin Inhibitors / Q000378:metabolism
D016228:Endothelial Growth Factors; D006133:Growth Substances; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors